Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis |
Tran, Thanh-Tam
(Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University)
Song, Won-Hyun (Hard-tissue Biointerface Research Center, School of Dentistry, Chonnam National University) Lee, Gyuseok (Hard-tissue Biointerface Research Center, School of Dentistry, Chonnam National University) Kim, Hyung Seok (Department of Forensic Science, Chonnam National University Medical School) Park, Daeho (School of Life Sciences, Gwangju Institute of Science and Technology) Huh, Yun Hyun (School of Life Sciences, Gwangju Institute of Science and Technology) Ryu, Je-Hwang (Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University) |
1 | Collins FW (1989) Oat phenolics: avenanthramides, novel substituted N-cinnamoylanthranilate alkaloids from oat groats and hulls. J Agric Food Chem 37, 60-66 DOI |
2 | Guo W, Wise ML, Collins FW and Meydani M (2008) Avenanthramides, polyphenols from oats, inhibit IL-1beta-induced NF-kappaB activation in endothelial cells. Free Radic Biol Med 44, 415-429 DOI |
3 | Roman-Blas JA and Jimenez SA (2006) NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil 14, 839-848 DOI |
4 | Othman RA, Moghadasian MH and Jones PJ (2011) Cholesterol-lowering effects of oat β-glucan. Nutr Rev 69, 299- 309 DOI |
5 | Guilak F (2011) Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheumatol 25, 815-823 DOI |
6 | Peterson, David & Hahn, Martha & Emmons and Cheryld (2002) Oat avenanthramides exhibit antioxidant activities in vitro. Food Chem 79, 473-478 DOI |
7 | Emmons CL, Peterson DM and Paul GL (1999) Antioxidant capacity of oat (Avena sativa L.) extracts. 2. In vitro antioxidant activity and contents of phenolic and tocol antioxidants. J Agric Food Chem 47, 4894-4898 DOI |
8 | Guo W, Nie L, Wu D et al (2010) Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro. Nutr Cancer 62, 1007-1016 DOI |
9 | Saklatvala J (2007) Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Curr Drug Targets 8, 305-313 DOI |
10 | Liu T, Zhang L, Joo D, Sun SC (2017) NF-κB signaling in inflammation. Signal Transduct Target Ther 2,17023 DOI |
11 | Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP and Fahmi H (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7, 33-42 DOI |
12 | Loeser RF, Goldring SR, Scanzello CR and Goldring MB (2012) Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64, 1697-1707 DOI |
13 | Yun S, Dardik A, Haga M et al (2002) Transcription factor Sp1 phosphorylation induced by shear stress inhibits membrane type 1-matrix metalloproteinase expression in endothelium. J Biol Chem 277, 34808-34814 DOI |
14 | Pulai JI, Chen H, Im HJ et al (2005) NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 174, 5781-5788 DOI |
15 | Loeser RF, Erickson EA and Long DL (2008) Mitogen-activated protein kinases as therapeutic targets in osteoarthritis. Curr Opin Rheumatol 20, 581-586 DOI |
16 | Kim JH, Jeon J, Shin M et al (2014) Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell 156, 730-43 DOI |
17 | Chang SH, Mori D, Kobayashi H et al (2019) Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-κB pathway. Nat Commun 10, 1442 DOI |
18 | Hashimoto M, Nakasa T, Hikata T and Asahara H (2008) Molecular network of cartilage homeostasis and osteoarthritis. Med Res Rev 28, 464-481 DOI |
19 | Yang S, Kim J, Ryu JH et al (2010) Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 16, 687-693 DOI |
20 | Goldring MB and Goldring SR (2007) Osteoarthritis. J Cell Physiol 213, 626-634 DOI |
21 | Roman-Blas JA and Jimenez SA (2006) NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil 14, 839-848 DOI |
22 | Mengshol JA, Vincenti MP, Coon CI, Barchowsky A and Brinckerhoff CE (2000) Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43, 801-811 DOI |
23 | Nakasa T, Adachi N, Kato T, Ochi M (2014) Correlation between subchondral bone plate thickness and cartilage degeneration in osteoarthritis of the ankle. Foot Ankle Int 35, 1341-1349 DOI |
24 | Zeng Li, Xiaofeng Rong, Rong-Heng Li and X Wu (2017) Icariin inhibits MMP 1, MMP 3 and MMP 13 expression through MAPK pathways in IL 1β stimulated SW1353 chondrosarcoma cells. Mol Med Rep 15, 2853-2858 DOI |
25 | Pan MR and Hung WC (2002) Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J Biol Chem 277, 32775-32780 DOI |
26 | Kang C, Shin WS, Yeo D, Lim W, Zhang T and Ji LL (2018) Anti-inflammatory effect of avenanthramides via NF-κB pathways in C2C12 skeletal muscle cells. Free Radic Biol Med 117, 30-36 DOI |
27 | Lim W and Kang C (2020) Avenanthramide C suppresses hypoxia-induced cyclooxygenase-2 expression through sirtuin1 activation in non-small-cell lung cancer cells. Anim Cells Syst 24, 79-83 DOI |
![]() |